FindTrial
Sign In

Clinical study of 0.01% atropine sulfate ophthalmic gel for myopia control

Clinical study of 0.01% atropine sulfate ophthalmic gel for myopia control

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000038218
Enrollment
Unknown
Registered
2020-09-14
Start date
2018-01-18
Completion date
Unknown
Last updated
2020-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ametropia

Interventions

1:0.01% atropine sulfate ophthalmic gel
2:Nil

Sponsors

Xi'an First Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 12 Years

Inclusion criteria

Inclusion criteria: Any child between the age of 6 and 12, either males or females, binocular myopia =1.0, astigmatism <=-2.0d, diagnosed refractive error obtained the informed consent of the children and their guardians can be recriuted in our study.

Exclusion criteria

Exclusion criteria: Any volunteer child with other eye diseases such as strabismus, amblyopia, high intraocular pressure (intraocular pressure higher than 21 MMHG) or glaucoma, cataract, fundus abnormalities, corneal ocular surface disease, allergy to atropine before, systemic diseases such as heart or lung disease, wearing contact lens, or without a written informed consent would be excluded from our study.

Design outcomes

Primary

MeasureTime frame
Refraction;Ocular axial length;—

Countries

China

Contacts

Public ContactYangzheng Wang

Xi'an First Hospital

2590051834@qq.com+86 13228055023

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026